Alkol Madde Kullanım Bozuklukları ve Fiziksel Hastalık Birlikteliği
Özet
Alkol ve madde kullanım bozuklukları, küresel ölçekte hastalık ve erken ölüm riskini artıran önemli faktörlerdir. Alkol tüketimi; gastrointestinal sistem fonksiyonlarını bozarak, DNA yapısını değiştirerek ve bağışıklığı zayıflatarak başta sindirim sistemi, karaciğer ve meme kanserleri olmak üzere tüm kanser türlerinin riskini yükseltmektedir. Karaciğer sirozu, hepatit, albüminüri ve kronik böbrek hasarı gibi çok sayıda fiziksel rahatsızlık alkol kullanımıyla doğrudan ilişkilidir. Kardiyovasküler alanda ise iskemik kalp hastalıkları, inme, hipertansiyon ve alkolik kardiyomiyopati gelişimini tetiklemektedir. Solunum sisteminde zatürre ve tüberküloz riskini artıran alkol, sinir sisteminde de deliryum tremens, Wernicke ensefalopatisi ve bunama gibi kalıcı hasarlara yol açar. Gebelikte alkol tüketimi teratojenik etkilerle fetal alkol sendromuna, düşük ve zihinsel engellere sebep olur. Metinde alkolün yanı sıra tütünün akciğer hastalıklarına; kafeinin tansiyon ve kolesterol değişimlerine; kannabis, halüsinojen ve uçucu maddelerin ölümcül aritmi, nörolojik hasar ve toksisiteye yol açtığı belirtilmiştir. Opioidlerin enfeksiyon riskini artırdığı, benzodiazepinlerin bilişsel gerileme yaptığı ve kokainin miyokard enfarktüsü riskini yedi kat artırdığı aktarılmıştır. Bu komorbiditelerin erken teşhisi hayati önem taşımaktadır.
Alcohol and substance use disorders are critical factors that increase global disease burden and early mortality risks. Alcohol consumption elevates the risk of all types of cancer, particularly gastrointestinal, liver, and breast cancers, by disrupting gastrointestinal functions, altering DNA structure, and weakening the immune system. Numerous physical conditions, including liver cirrhosis, hepatitis, albuminuria, and chronic kidney disease, are directly associated with alcohol intake. In the cardiovascular domain, it triggers ischemic heart diseases, stroke, hypertension, and alcoholic cardiomyopathy. Alcohol increases the susceptibility to pneumonia and tuberculosis in the respiratory system, while inducing irreversible damage in the nervous system, such as delirium tremens, Wernicke's encephalopathy, and dementia. During pregnancy, alcohol consumption exerts teratogenic effects, leading to fetal alcohol syndrome, miscarriage, and intellectual disabilities. Alongside alcohol, the text notes that tobacco causes lung diseases; caffeine affects blood pressure and cholesterol levels; while cannabis, hallucinogens, and volatile substances lead to fatal arrhythmias, neurological damage, and toxicity. Furthermore, opioids increase infection risks, benzodiazepines cause cognitive decline, and cocaine elevates the risk of myocardial infarction sevenfold. Early screening and diagnosis of these comorbidities are vital for prevention and treatment.
Referanslar
Peacock A, Leung J, Larney S, et al. Global statistics on alcohol, tobacco and illicit drug use: 2017 status report. Addiction. 2018;113(10):1905-1926. Doi: 10.1111/add.14234
World Health Organization. Global status report on alcohol and health 2018.[Online]https://www.who.int/substance_abuse/publications/global_alcohol_report/en/ [Accessed: 27 September 2018]
Griswold MG, Fullman N, Hawley C, et al. Alcohol use and burden for 195 countries and territories, 1990-2016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet 2018; 392(10152): 1015-35. Doi: 10.1016/S0140-6736(18)31310-2
Burton R, Sheron N. No level of alcohol consumption improves health. Lancet. 2018;392(10152):987-8. Doi: 10.1016/S0140-6736(18)31571-X
Rehm J, Soerjomataram I, Ferreira-Borges C, et al. Does alcohol use affect cancer risk? Curr Nutr Rep 2019. Doi: 10.1007/s13668-019-0267-0
Department of Health (UK). UK Chief Medical Officers' Alcohol Guidelines Review Summary of the proposed new guidelines [Online]. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/489795/summary.pdf [Accessed: January 2016]
Connor J. Alcohol consumption as a cause of cancer. Addiction. 2017; 112(2): 222-8. Doi: 10.1111/add.13477
Simpson RF, Hermon C, Liu B, et al. Alcohol drinking patterns and liver cirrhosis risk: Analysis of the prospective UK Million Women Study. The Lancet Public Health. 2019;4(1):e41-e48. Doi: 10.1016/S2468-2667(18)30230-5
Hydes T, Gilmore W, Sheron N, et al. Treating alcohol-related liver disease from a public health perspective. J Hepatol. 2019;70(2): 223-36. Doi: 10.1016/j.jhep.2018.10.036
Pan CS, Ju TR, Lee CC, et al. Alcohol use disorder tied to development of chronic kidney disease: A nationwide database analysis. PLoS One 2018; 13(9): e0203410. Doi: 10.1371/journal.pone.0203410
World Health Organization. Alcohol and Health - WHO 2018 infographic. [Online]https://alcoholcampaign.org/2018/11/10/alcohol-and-health-who-2018-infographic/ [Accessed: 10 November 2018]
Manthey J, Probst C, Rylett M, et al. National, regional and global mortality due to alcoholic cardiomyopathy in 2015. Heart 2018;104(20):1663-9. Doi: 10.1136/heartjnl-2017-312384
Zhou Y, Zheng J, Li S, et al. Alcoholic beverage consumption and chronic diseases. Int J Environ Res Public Health 2016;13(6). Doi: 10.3390/ijerph13060522
Fuchs FD, Chambless LE, Whelton PK, et al. Alcohol consumption and the incidence of hypertension: The Atherosclerosis Risk in Communities Study. Hypertension 2001;37(5):1242-50. Doi: 10.1161/01.hyp.37.5.1242
Toma A, Pare G, Leong DP. Alcohol and cardiovascular disease: How much is too much? Curr Atheroscler Rep. 2017;19(3):13. Doi: 10.1007/s11883-017-0647-0
Simou E, Britton J, Leonardi-Bee J. Alcohol and the risk of pneumonia: A systematic review and meta-analysis. BMJ Open. 2018;8(8):e022344. Doi: 10.1136/bmjopen-2018-022344
World Health Organization. Global tuberculosis report 2018 [Online]. https://www.who.int/tb/publications/global_report/en/ [Online].
Imtiaz S, Shield KD, Roerecke M, et al. Alcohol consumption as a risk factor for tuberculosis: Meta-analyses and burden of disease. Eur Respir J. 2017;50(1):1700216. Doi: 10.1183/13993003.00216-2017
Rachdaoui N, Sarkar DK. Pathophysiology of the Effects of Alcohol Abuse on the Endocrine System. Alcohol Res. 2017; 38(2): 255–276.
Obad A, Peeran A, Little JI, et al. Alcohol-mediated organ damages: heart and brain. Front Pharmacol. 2018;9:81.
Planas-Ballvé A, Grau-López L, Morillas RM, et al. Manifestaciones neurológicas del alcoholismo. Gastroenterología y Hepatología. 2017;40(10): 709-717. Doi: 10.1016/j.gastrohep.2017.05.011
Hammoud N, Shahed JJ. Chronic Neurologic Effects of Alcohol. Clin Liver Dis. 2019;23:141–155. Doi: 10.1016/j.cld.2018.09.010
Wieczorek M, Gwinnutt JM, Ransay-Colle M,et al. Smoking, alcohol consumption and disease-specific outcomes in rheumatic and musculoskeletal diseases (RMDs): systematic reviews informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs. RDM open;2020:8(1),e002170. Doi: 10.1136/rmdopen-2021-002170
Mangla G, Garg N, Bansal D, et al. Peripheral Blood and Bone Marrow Findings in Chronic Alcoholics with Special Reference to Acquired Sideroblastic Anemia. Indian J Hematol Blood Transfus. 2020;36(3):559-564. Doi: 10.1007/s12288-019-01188-5
Shi X, DeLucia AL, Bao J, et al. Alcohol abuse and disorder of granulopoiesis. Pharmacol Ther. 2019;198:206-219. Doi: 10.1016/j.pharmthera.2019.03.001
Bujanda L. The Effects of Alcohol Consumption Upon the Gastrointestinal. Tract. Am J Gastroenterol 2000;95: 3374–3382. Doi: 10.1111/j.1572-0241.2000.03347.x
Jain NP, Shao K, Stewart C, et al. The effects of alcohol and illicit drug use on the skin. Clin Dermatol. 2021;39(5):772-783. Doi: 10.1016/j.clindermatol.2021.05.005
Wolverton SE, Wu JJ. Comprehensive dermatologic drug therapy. Elsevier Health Sciences. 2019
Kelly Y, Iacovou M, Quigley MA, et al. Light drinking versus abstinence in pregnancy - behavioural and cognitive outcomes in 7-year-old children: a longitudinal cohort study. BJOG 2013; 120(11): 1340-7. Doi: 10.1111/1471-0528.12246
Mamluk L, Edwards HB, Savoviç J, et al. Effects of low alcohol consumption on pregnancy and childhood outcomes: A systematic review and meta-analysis. The Lancet 2016; 388: S14. Doi: 10.1136/bmjopen-2016-015410
Kahila H, Halmesmaki E, Baldacchino A, et al. EBCOG position paper on alcohol and pregnancy. Eur J Obstet Gynecol Reprod Biol 2016; 202: 99-100. Doi: 10.1016/j.ejogrb.2016.04.020
Centers for Disease Control and Prevention (CDC). An alcohol-free pregnancy is the best choice for your baby. [Online] https://www.cdc.gov/ncbddd/fasd/documents/fasdbrochure_final.pdf [Accessed: 20 May 2016]
Tsang TW, Elliott EJ. High global prevalence of alcohol use during pregnancy and fetal alcohol syndrome indicates need for urgent action. Lancet Glob Health 2017; 5(3): e232-e233. Doi: 10.1016/S2214-109X(17)30008-6
Santoroa A, Tominob C, Prinzia G, et al. Tobacco Smoking: Risk to Develop Addiction, Chronic Obstructive Pulmonary Disease and Lung Cancer. Recent Patents on Anti-Cancer Drug Discovery. 2019;14:39-52.Doi: 10.2174/1574892814666190102122848
Münzel, T, Hahad O, Kuntic M, et al. Effects of tobacco cigarettes, e-cigarettes, and waterpipe smoking on endothelial function and clinical outcomes. European heart journal. 2020;41(41): 4057–4070. Doi: 10.1093/eurheartj/ehaa460
Lin CC, Chiu CC, Lee PY, et al. The Adverse Effects of Air Pollution on the Eye: A Review. International journal of environmental research and public health. 2022;19(3):1186. Doi: 10.3390/ijerph19031186
Juliano LM, Griffiths RR. A critical review of caffeine withdrawal: empirical validation of symptoms and signs, incidence, severity, and associated features. Psychopharmacology. 2004;176:1-29. Doi: 10.1007/s00213-004-2000-x
Grosso G, Micek A, Godos J, et al. Long-term coffee consumption is associated with decreased incidence of newonset hypertension: a dose-response metaanalysis. Nutrients. 2017;9:890. Doi: 10.3390/nu9080890
Jee SH, He J, Appel LJ, et al. Coffee consumption and serum lipids: a meta-analysis of randomized controlled clinical trials. Am J Epidemiol. 2001;153:353-62. Doi: 10.1093/aje/153.4.353
Sözlü S, Yılmaz B, Acar Tek N, et al. Kahve Tüketimi ve Bazı Hastalıklarla İlişkisi. Sdü Sağlık Bilimleri Enstitüsü Dergisi. 2017;8(2):33-39. Doi: 10.22312/sdusbed.273937
Cnattingius S, Signorello LB, Annerén G, et al. Caffeine intake and the risk of first-trimester spontaneous abortion. N. Engl. J. Med. 2000;343:1839–1845. Doi: 10.1056/NEJM200012213432503
Lyngso J, Ramlau-Hansen CH, Bay B, et al. Association between coffee or caffeine consumption and fecundity and fertility: a systematic review and dose-response meta-analysis. Clin. Epidemiol. 2017;9:699–719. Doi: 10.2147/CLEP.S146496
Tait R, Caldicott D, Mountain D, et al. A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment. Clin Toxicol (Phila). 2016;54(1):1–13. Doi: 10.3109/15563650.2015.1110590
Brezing CA, Levin FR. The Current State of Pharmacological Treatments for Cannabis Use Disorder and Withdrawal Neuropsycho pharmacology Reviews. 2018;43:173–194. Doi: 10.1038/npp.2017.212
Scocard A, Benyamina A, Coscas S, et al. Cannabinoïdes de synthase: une nouvelle matrice des addictions. Presse Med. 2017;46(1):11–22. Doi: 10.1016/j.lpm.2016.11.014
Labay L, Caruso JL, Gilson T, et al. Synthetic cannabinoid drug use as a cause or contributory cause of death. Forensic Sci int. 2016;260:31–39.Doi: 10.1016/j.forsciint.2015.12.046
Hardaway R, Schweitzer J, Suzuki J. Hallucinogen Use Disorders. Child and Adolescent Psychiatric. Clinics of North America. 2016;25: 489-496. Doi: 10.1016/j.chc.2016.03.006
Wright NE, Strong JA, Gilbart ER, et al. 5-HTTLPR genotype moderates the effects of past ecstasy use on verbal memory performance in adolescent and emerging adults: a pilot study. PLoS One 2015;10(7):e0134708. Doi: 10.1371/journal.pone.0134708
Tormoehlen LM, Tekulve KJ, Nanagas KA. Hydrocarbon toxicity: A review, Clinical Toxicology. 2014;52:479-489.Doi: 10.3109/15563650.2014.923904
Scott EB. Two Serious and Challenging Medical Complications Associated with Volatile Substance Misuse: Sudden Sniffing Death and Fetal Solvent Syndrome. Substance Use & Misuse. 2011;46(1):68-72. Doi: 10.3109/10826084.2011.580220
Van Valen E, van Thriel C, Akila R, et al. Chronic solvent-induced encephalopathy: European consensus of neuropsychological characteristics, assessment, and guidelines for diagnostics . Neurotoxicology. 2012;33:710 – 726. Doi: 10.1016/j.neuro.2012.03.010
Kopec KT, Brent J, Banner W, et al. Management of cardiac dysrhythmias following hydrocarbon abuse: clinical toxicology teaching case from NACCT acute and intensive care symposium . J Toxicol Clin Toxicol 2014;52:141 – 145 . Doi: 10.3109/15563650.2014.882001
Mazzeo PA, Renny M, Osterhoudt KC. A toddler with curiosity and a cough. Pediatr Emerg Care. 2010;26:232–235. Doi: 10.1097/PEC.0b013e3181d5297e
Streicher HZ , Gabow PA , Moss AH, et al. Syndromes of toluene sniffi ng in adults . Ann Intern Med. 1981; 94:758 –762. Doi: 10.7326/0003-4819-94-6-758
Mravcík V, Sebáková H, Kania A. Seroprevalence of viral hepatitis A, B and C in intravenous drug users. Epidemiol Mikrobiol Imunol. 2000;49(1):19-23
Chambers HF. Skin and Soft Tissue Infections in Persons Who Inject Drugs. Infect Dis Clin North Am. 2021 Mar;35(1):169-181. doi: 10.1016/j.idc.2020.10.006. Epub 2020 Dec 7. PMID: 33303334.Doi: 10.1016/j.idc.2020.10.006
Ji Y, Kujtan L, Kershner D. Acute endocarditis in intravenous drug users: a case report and literature review. Journal of community hospital internal medicine perspectives. 2012;2(1),1-4. Doi: 10.3402/jchimp.v2i1.11513
Smink BE, Egberts AC, Lusthof KJ, et al. The relationship between benzodiazepine use and traffic accidents: a systematic literature review. CNS Drugs. 2010;24:639-53. Doi: 10.2165/11533170-000000000-00000
Berryman SN, Jennings J, Ragsdale S, et al. Beers criteria for potentially inappropriate medication use in older adults. Medsurg Nurs. 2012;21:129-32.
Pariente A, de Gage SB, Moore N, et al. The benzodiazepine-dementia disorders link: current state of knowledge. CNS Drugs. 2016;30:1-7. Doi: 10.1007/s40263-015-0305-4
Horsfall JT, Sprague JE. The Pharmacology and Toxicology of the 'Holy Trinity'. Basic Clin Pharmacol Toxicol. 2017;120(2):115-119. Doi: 10.1111/bcpt.12655
Dugo, E, Barison A, Todiere G, et al. Cardiac magnetic resonance in cocaine-induced myocardial damage: cocaine, heart, and magnetic resonance. Heart Fail Rev. 2022;27:111–118. Doi: 10.1007/s10741-020-09983-3
Tseng W, Sutter ME, Albertson TE. Stimulants and the lung. Clin Rev Allergy Immunol. 2014;46(1):82–100. Doi: 10.1007/s12016-013-8376-9
Fernandez WG, Hung O, Bruno GR, et al. Factors predictive of acute renal failure and need for hemodialysis among ED patients with rhabdomyolysis. Am J Emerg Med. 2005;23(1):1–7. Doi: 10.1016/j.ajem.2004.09.025
Toosi S, Hess CP, Hills NK, et al. Neurovascular complications of cocaine use at a tertiary stroke center. J Stroke Cerebrovasc Dis. 2010;19(4):273–8. Doi: 10.1016/j.jstrokecerebrovasdis.2009.05.002
Neiman J, Haapaniemi HM, Hillbom M. Neurological complications of drug abuse: pathophysiological mechanisms. Eur J Neurol. 2000;7(6):595–606. Doi: 10.1046/j.1468-1331.2000.00045.x
Trimarchi M, Bussi M, Sinico RA, et al. Cocaine-induced midline destructive lesions – an autoimmune disease? Autoimmun Rev. 2013;12:496–500. Doi: 10.1016/j.autrev.2012.08.009
Ip JE, Lu DH, Barnett MJ, et al. Psychological and Physical Impact of Anabolic-Androgenic Steroid Dependence. Pharmacotherapy. 2012;32(10):910–919. Doi: 10.1002/j.1875-9114.2012.01123
Walker ER, Druss BG. Mental and Addictive Disorders and Medical Comorbidities. Current Psychiatry Reports. 2018;20:10–11.Doi: 10.1007/s11920-018-0956-1
